However, patients who built strong protein-based nutrition habits, maintained muscle mass through resistance exercise, and followed a physician-guided tapering plan maintain significantly more of their weight loss
doi:10.1016/j.amjcard.2006.12.044 70
Considering promising preclinical data (Table 1) and clinical pilot study results in the GLP-2 analog, teduglutide may have potential to become a new therapeutic option in IBD treatment, showing higher response and remission rates in comparison to placebo (Buchman et al
However, patients on these medications exhibited profound weight-loss, prompting Novo, Lilly, Amgen, and other pharma companies to investigate how these drugs can be used specifically to treat obesity
For many people, the convenience and specialist access of telehealth outweigh the benefits of in-person visits
To avoid the tirzepatide rebound effect , make lifestyle changes like healthy eating and exercise